Dowden Nathan J (CIK 1873392) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Sell TRDA (2,528 shares), Buy TRDA (15,000 shares), Sell TRDA (15,000 shares), Sell TRDA (3,116 shares), Sell TRDA (11,894 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 2,528 | $18,060 |
| 2026-05-04 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Buy | 15,000 | $26,100 |
| 2026-05-04 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 15,000 | $229,950 |
| 2026-03-11 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 3,116 | $40,570 |
| 2026-03-11 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 11,894 | $155,217 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Buy | 55,800 | $0 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 7,223 | $84,220 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 14,038 | $165,087 |
| 2025-09-04 | Entrada Therapeutics, Inc. (TRDA) | President & COO | Sell | 1,746 | $9,481 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03